WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: REVLIMID

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on REVLIMID

Proof of use for REVLIMID

We do not have any records of a proof of use for REVLIMID at this moment.

Click here to add a proof of use for REVLIMID

Possible trademark infringements of REVLIMID

Basic Information about REVLIMID

Serial Number
78188450
Filing Date
25 Nov 2002
Registration Number
2925808
Registration Date
08 Feb 2005
Mark Drawing Code
1

Classifications

Declare the trademark use of REVLIMID on the blockchain with WikiTrademarks.io.

First use of REVLIMID anywhere
REVLIMID was first used on 19 Feb 2004 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns REVLIMID?

1. Celgene Corporation Summit NJ

2. Celgene Corporation Warren NJ

3. Celgene Corporation Warren NJ

Correspondent

Marilyn F. Kelly Bristol-Myers Squibb Company
PO BOX 4000
Trademark Dept., Mailstop D.4243
PRINCETON, NJ 08648

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on REVLIMID